undamentalytics Newsletter
Sign in

Guardant Health, Inc. revenue

Guardant Health, Inc.'s revenue was $982m in fiscal 2025, up 32.9% on the year before. Since fiscal 2016 ($25.2m) it has grown at a compound 50.2% a year. Over the last twelve months it was $1.18bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2550912142873744505647399821,183
Growth on the year before—+97.4%+81.9%+136.5%+33.8%+30.3%+20.3%+25.5%+31.0%+32.9%—
Gross profit———————337449633769
Gross margin———————59.7%60.8%64.5%65.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Oncology $684M 69.6% ▲ 25.9%
Biopharma Data $210M 21.4% ▲ 18.3%
Screening $79.7M 8.1% ▲ 1456.0%
Licensing Other $8.6M 0.9% ▼ 36.5%
Geography
Region Revenue Share YoY
United States $923M 94.0% ▲ 32.4%
Outside the US $58.7M 6.0% ▲ 40.3%

From Guardant Health, Inc.'s 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Guardant Health, Inc. $1.18bn 42.7% 32.4%
Pennant Group, Inc. $1.10bn 37.9% 30.0%
Progyny, Inc. $1.31bn 5.5% 11.0%
Healthequity, Inc. $1.36bn 7.3% 13.2%
Innovage Holding Corp. $990m 15.9% 12.9%
Corvel Corp $984m 7.1% 10.3%

Compare with peers

Head to head: GH vs PNTGGH vs PGNYGH vs HQYGH vs INNV

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Guardant Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Guardant Health, Inc.